AI holds immense possibility for transforming clinical trials – a transformation that has already begun.
From drug discovery and planning through operational execution to post-marketing, AI can accelerate processes and enhance efficiencies to bring life-saving therapies to market faster.
Realising the benefits of AI across key areas, however, requires a methodical approach to developing mature and responsive solutions.
Check out the rest of the feature here
